Alterola Biotech, Inc. (ABTI)
Alterola Biotech, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Birkenhead, MR, GB. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $291,900. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of 0.0%. Its beta of 1.52 implies it has historically moved more than the broad market.
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.
Alterola Biotech, Inc. is most often compared with the following Healthcare names: